FLASH SALE: Subscribe For Just ₹̶2̶9̶9̶9̶ ₹699
India's Wockhardt Starts Global Phase 3 Study Of Its Super Drug 'WCK 5222' To Treat Antibiotic-Resistant Bacterial Infections
Indian Scientists Develop Novel Strategy For Revitalising Obsolete Antibiotics To Counter Multi-Drug Resistant Bacteria
Use And Abuse Of Antibiotics: A Critical Public Health Emergency On The Horizon